Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-03-20
1998-01-13
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142282, 5142352, 514255, 514316, 514318, 514339, 544 62, 544129, 544124, 544360, 544373, 546187, 546193, 546201, 5462774, A61K 31445, C07D40104
Patent
active
057080089
ABSTRACT:
This invention provides novel 5-HT.sub.1F agonists of Formula I ##STR1## where A--B, R, R.sup.1 and X are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
REFERENCES:
patent: 3850938 (1974-11-01), Derible et al.
patent: 4278677 (1981-07-01), Nedelec et al.
patent: 4359468 (1982-11-01), Freter et al.
patent: 4530932 (1985-07-01), Clemence et al.
patent: 4710500 (1987-12-01), Perregaard
patent: 4742057 (1988-05-01), Ueda et al.
patent: 4997841 (1991-03-01), Oxford et al.
patent: 5001135 (1991-03-01), Oxford et al.
patent: 5017703 (1991-05-01), Matsuo et al.
patent: 5036078 (1991-07-01), Coates
patent: 5066660 (1991-11-01), Oxford et al.
patent: 5118691 (1992-06-01), Jaen et al.
patent: 5187280 (1993-02-01), Jaen et al.
patent: 5216001 (1993-06-01), Perregaard et al.
patent: 5298520 (1994-03-01), Baker et al.
patent: 5317025 (1994-05-01), Bru-Magniez et al.
patent: 5322851 (1994-06-01), Perregaard et al.
patent: 5545644 (1996-08-01), Moor et al.
Moskowitz, M.A. et al, J. Neurology, 1991, 238 Suppl. 1, pp. S18-22, ref: 29. Online Abstract relied upon.
Hansch, Corwin, and Caldwell, Jonathan; Journal Computer-Aided molecular Design, 5, 441-453 (1991).
Taylor, et al., Molecular Pharmacology, 34, 42-52 (1988).
Agarwal, et al., J. Med. Chem., 36, 4006-4014 (1993).
Macor, John, Presentation: "Serotonin in Neuroscience", Philadelphia, Sep. 27-29, (1994).
M.A. Moskowitz, et al., Journal of Neurology, (1991), 258:S18-S22.
Taylor, et al., Molecular Pharmacology, vol. 34, No. 1, (Jul. 1988), pp. 42-54.
Audia James Edmund
Dressman Bruce Anthony
Droste James Joseph
Fritz James Erwin
Kaldor Stephen Warren
Boone David E.
Danlen Garth
Eli Lilly and Company
Ivy C. Warren
Titus Robert D.
LandOfFree
5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326614